Prescription opioid abuse, pain and addiction: clinical issues and implications
about
Supervised dosing with a long acting opioid medication in the management of opioid dependenceChanging channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilitySupervised dosing with a long-acting opioid medication in the management of opioid dependence.Assessment of the effects of contingent histamine injections on the reinforcing effectiveness of cocaine using behavioral economic and progressive-ratio designs.Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.BETWEEN A ROCK AND A HARD PLACE: CAN PHYSICIANS PRESCRIBE OPIOIDS TO TREAT PAIN ADEQUATELY WHILE AVOIDING LEGAL SANCTION?An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions.Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.Pain Among High-Risk Patients on Methadone Maintenance TreatmentClinical implications of drug abuse epidemiologyDependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study.Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.Using behavioral economics to predict opioid use during prescription opioid dependence treatment.Risk for prescription opioid misuse among patients with a history of substance use disorderPain treatment in arthritis-related pain: beyond NSAIDs.Update on prescription extended-release opioids and appropriate patient selection.Current analgesic use predicts low emotional quality of life in youth: a cross-sectional survey among university students in Sikkim, North East India.Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims.Gene therapy for the treatment of chronic peripheral nervous system pain.Palliative care research: lessons learned by our team over the last 25 years.Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs.Expression and treatment of pain-related behavioral depression.Nociception and pain: lessons from optogenetics.Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal painVolatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Triage in opioid replacement therapy: what's the wait?A qualitative analysis of family involvement in prescribed opioid medication monitoring among individuals who have experienced opioid overdoses.Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.Repetitive Transcranial Magnetic Stimulation in Chronic Pain: A Meta-analysisChronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.A Novel Chronic Opioid Monitoring Tool to Assess Prescription Drug Steady State Levels in Oral Fluid.Perceived stigma and social support in treatment for pharmaceutical opioid dependence.Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.Transgenerational modification of hippocampus TNF-α and S100B levels in the offspring of rats chronically exposed to morphine during adolescence.Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABAA Receptor Positive Allosteric Modulator.Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.
P2860
Q24187551-522D0B53-17FB-47A5-A619-A337CA19020CQ28081164-1419CB46-BBD1-4598-9132-F628C869F336Q30234632-4D4C498C-3B18-457A-94D2-628C70C137C7Q33693299-6AFF0B57-85DF-409F-BAD7-4479A3584F33Q33697613-2F19EC32-CB5A-441A-8824-BB2C415E3C3EQ33862759-DDB115BA-60AA-40EC-956D-0296C8DB0B1DQ34069379-0BC62833-046D-4308-8147-886BC29B17FDQ35278475-0445D2D9-1AEE-4A62-8C0A-8F89E16AA367Q36016599-FC246426-350E-4C2F-869A-049DBF62E13EQ36057853-84E75F78-D8CC-41FA-B85F-851CDD556DA4Q36131787-8EDB2931-276E-4979-A115-8DA5C9578BBEQ36315633-83D67557-EF73-44D7-BD43-0F4944117DECQ36338434-0C48AEA1-6EB8-4578-A2D8-4EEEA06624ECQ36357013-3923E831-D436-4944-A092-6E2FF3432327Q36481613-EF143AC6-DDBF-40A7-B464-2F1B86FCB601Q37053718-29178237-B74E-4BF9-AA29-CEB179339C18Q37073259-B7D1FBB8-2418-4431-A691-AA5ACA4C73CFQ37164033-57C9BB37-7E42-48BA-82D2-37C3D92FFE5DQ37592812-5D8483F9-F202-4669-8944-2DA891E99BAEQ38016275-2B022F87-458D-49D4-A0DA-5447A2BB8902Q38084807-61DACB5E-2439-4B8F-857E-758108EFEE2CQ38101985-C4790F10-4805-4B5A-A52C-A1CCD96A7FEAQ38123399-EA58462F-391C-49EB-AEF9-DA1F65C17C95Q38203871-02E74FCC-6836-4DD3-9480-88BCEE76D459Q38400356-D39492DE-D211-4B07-A6DA-2E83F75ADC8EQ38977492-98D1F05F-9775-430A-9A91-450EED969A70Q39027669-5A0EE80A-4088-4931-8EDA-8EAC6AD698EBQ40073213-C1E13B14-D632-41EF-8CA5-0B38AE0ED21FQ40235338-40F323B7-249B-4B78-9C51-2BB503246D00Q40777843-D6D12223-A197-4F4A-AAC2-A2A6AAA2DF63Q41260484-896B93C6-97D3-4B42-9F3C-58BF5485E3FDQ43075740-8E891408-4E42-485E-8595-8334164C3E14Q44339136-FC8AE7D1-C33F-4F9B-BEF7-81F34E91BA25Q44348718-0A20D507-72E2-4E12-9ED8-54805950F68CQ46124116-7C72B15A-2515-4F58-9E26-517DFEDFE5E6Q47245240-95DBDCF6-096D-4197-8258-19E2692B858EQ47684883-67EED05B-7AD3-4E83-99F4-9EA9A6F1776AQ48284984-7CDA93E1-AF0B-4B95-8988-DE76129126E5Q49961197-CCDBAC9B-1C4A-48B8-B2C8-FA361F785F33Q50026534-F74C5B8F-0B39-452C-9EA8-16CD80636D93
P2860
Prescription opioid abuse, pain and addiction: clinical issues and implications
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prescription opioid abuse, pain and addiction: clinical issues and implications
@ast
Prescription opioid abuse, pain and addiction: clinical issues and implications
@en
Prescription opioid abuse, pain and addiction: clinical issues and implications
@nl
type
label
Prescription opioid abuse, pain and addiction: clinical issues and implications
@ast
Prescription opioid abuse, pain and addiction: clinical issues and implications
@en
Prescription opioid abuse, pain and addiction: clinical issues and implications
@nl
prefLabel
Prescription opioid abuse, pain and addiction: clinical issues and implications
@ast
Prescription opioid abuse, pain and addiction: clinical issues and implications
@en
Prescription opioid abuse, pain and addiction: clinical issues and implications
@nl
P2093
P2860
P1476
Prescription opioid abuse, pain and addiction: clinical issues and implications
@en
P2093
Larissa Mooney
Maureen Hillhouse
Walter Ling
P2860
P304
P356
10.1111/J.1465-3362.2010.00271.X
P577
2011-05-01T00:00:00Z